Posted in | News | Medical Robotics

Ekso Bionics Featured in Robotics Business Review Industry Special Report

Ekso Bionics Holdings, Inc., a robotic exoskeleton company, today announced that it was featured in Robotics Business Review Industry Special Report 'Healthcare Robotics: 2014' that describes medical robotic exoskeletons as "probably the most exciting segment of the entire medical robotics market right now."

Ekso Bionics Cover of Robotics Business Review

Donald Jones, Managing Director of Draper Triangle Ventures is quoted saying, "My guess is that in five years, there will be ten times the number of robots deployed in hospitals that there are today. We are just not going to have enough human hands to do all the work."

Ekso Bionics designs, develops, and commercializes exoskeletons, or wearable robots, which have a variety of applications in the medical, military, industrial, and consumer markets. Exoskeletons are ready-to-wear, battery-powered robots that are strapped over the user's clothing, enabling individuals to achieve mobility, strength, and endurance not otherwise possible.

Ekso Bionics' lead product, EksoTM, is a wearable bionics suit that enables individuals with any amount of lower extremity weakness to stand up and walk over ground. Ekso is forging a new frontier in rehabilitation for people living with the consequences of stroke, spinal cord injury and other neurological conditions affecting gait.

Source: http://www.eksobionics.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.